Dendrimer Prodrugs

The main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic pr...

Full description

Bibliographic Details
Main Authors: Soraya da Silva Santos, Elizabeth Igne Ferreira, Jeanine Giarolla
Format: Article
Language:English
Published: MDPI AG 2016-05-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/21/6/686
id doaj-018293896c1a45b7a3a4949997578b15
record_format Article
spelling doaj-018293896c1a45b7a3a4949997578b152020-11-24T21:12:09ZengMDPI AGMolecules1420-30492016-05-0121668610.3390/molecules21060686molecules21060686Dendrimer ProdrugsSoraya da Silva Santos0Elizabeth Igne Ferreira1Jeanine Giarolla2Laboratory of Design and Synthesis of Chemotherapeutics Potentially Active in Neglected Diseases (LAPEN), Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo—USP, Avenue Professor Lineu Prestes, 580–Building 13, São Paulo SP, 05508-900, BrazilLaboratory of Design and Synthesis of Chemotherapeutics Potentially Active in Neglected Diseases (LAPEN), Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo—USP, Avenue Professor Lineu Prestes, 580–Building 13, São Paulo SP, 05508-900, BrazilLaboratory of Design and Synthesis of Chemotherapeutics Potentially Active in Neglected Diseases (LAPEN), Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo—USP, Avenue Professor Lineu Prestes, 580–Building 13, São Paulo SP, 05508-900, BrazilThe main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic properties of prototype, to promote drug sustained-release, to increase selectivity and, consequently, to decrease toxicity, are just some examples of topics that have been extensively reported in the literature, especially in the last decade. The examples discussed here give a panel of the growing interest dendrimer prodrugs have been evoking in the scientific community.http://www.mdpi.com/1420-3049/21/6/686dendrimerprodrugsmolecular modificationstargeted dendrimerpharmaceutical applications
collection DOAJ
language English
format Article
sources DOAJ
author Soraya da Silva Santos
Elizabeth Igne Ferreira
Jeanine Giarolla
spellingShingle Soraya da Silva Santos
Elizabeth Igne Ferreira
Jeanine Giarolla
Dendrimer Prodrugs
Molecules
dendrimer
prodrugs
molecular modifications
targeted dendrimer
pharmaceutical applications
author_facet Soraya da Silva Santos
Elizabeth Igne Ferreira
Jeanine Giarolla
author_sort Soraya da Silva Santos
title Dendrimer Prodrugs
title_short Dendrimer Prodrugs
title_full Dendrimer Prodrugs
title_fullStr Dendrimer Prodrugs
title_full_unstemmed Dendrimer Prodrugs
title_sort dendrimer prodrugs
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2016-05-01
description The main objective of this review is to describe the importance of dendrimer prodrugs in the design of new drugs, presenting numerous applications of these nanocomposites in the pharmaceutical field. Therefore, the use of dendrimer prodrugs as carrier for drug delivery, to improve pharmacokinetic properties of prototype, to promote drug sustained-release, to increase selectivity and, consequently, to decrease toxicity, are just some examples of topics that have been extensively reported in the literature, especially in the last decade. The examples discussed here give a panel of the growing interest dendrimer prodrugs have been evoking in the scientific community.
topic dendrimer
prodrugs
molecular modifications
targeted dendrimer
pharmaceutical applications
url http://www.mdpi.com/1420-3049/21/6/686
work_keys_str_mv AT sorayadasilvasantos dendrimerprodrugs
AT elizabethigneferreira dendrimerprodrugs
AT jeaninegiarolla dendrimerprodrugs
_version_ 1716751420072394752